Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An <i>In Vivo</i> Study Using Spectral Domain OCT

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">Hyperreflective spots/number (±SD)</td><td align="center" rowspan="2">Control</td><td align="center" colspan="2">                    Diabetic<br/></td></tr><tr class="thead"><td align="center">         No DR</td><td align="center">NPDR</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">ILM-GCL</td><td align="center">00.5 (0.22)</td><td align="center">2.92 (1.88)</td><td align="center">6.63 (2.5)</td></tr><tr><td align="left">INL-OPL</td><td align="center">0.03 (0.48)</td><td align="center">2.93 (1.73)</td><td align="center">8.03 (3.18)</td></tr><tr><td align="left">ONL</td><td align="center">0.00 (0.00)</td><td align="center">1.58 (1.31)</td><td align="center">6.18 (2.89)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>SD: standard deviation; No DR: diabetic patients without retinopathy; NPDR: nonproliferative diabetic retinopathy; ILM-GCL: inner limiting membrane-ganglion cell layer; INL-OPL: inner nuclear layer-outer plexiform layer; ONL: outer nuclear layer.<br/></td></tr></table>

Journal of Diabetes Research

tab2

Table 2

Table 2: Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An <i>In Vivo</i> Study Using Spectral Domain OCT 

Table 2 | Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An In Vivo Study Using Spectral Domain OCT 